Curtis, SL, Norman, BP 
ORCID: 0000-0001-9293-4852, Milan, AM ORCID: 0000-0002-0452-2338, Gallagher, JA, Olsson, B, Ranganath, LR and Roberts, NB
(2019)
Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone.
CLINICAL BIOCHEMISTRY, 71.
pp. 24-30.
|
Text
Interference of hydroxyphenylpyruvic acid_FinalAccepted.pdf - Author Accepted Manuscript Download (517kB) | Preview |
Abstract
<h4>Objectives</h4>We have assessed the effect of elevated concentrations of hydroxyphenylpyruvic acid (HPPA), hydroxyphenyllactic acid (HPLA) and tyrosine, on a range of chemistry tests in serum and urine to explore the potential for chemical interference on routine laboratory analyses in patients with alkaptonuria (AKU) treated with nitisinone and similarly implications for patients with hereditary tyrosinemia type 1 (HT-1).<h4>Materials and methods</h4>HPPA, HPLA and tyrosine were added separately to pooled serum from subjects without AKU in a range of assays with Roche Modular chemistries. Effects on urine were assessed by changes in urine strip chemistries after mixing a positive control urine with various amounts of the test compounds and reading on a Siemens urine strip meter.<h4>Results</h4>No significant effect (p > 0.1) was observed up to 225 μmol/L of HPPA and HPLA, and up to 5000 μmol/L tyrosine, on any of the serum-based assays including those with peroxidase-coupled reaction systems of enzymatic creatinine, urate, total cholesterol, HDL cholesterol and triglyceride. Both the monohydroxy HPPA, and the dihydroxy homogentisic acid (HGA), at increased urine concentrations typical of nitisinone-treated AKU and non-treated AKU respectively, did however show marked negative interference in strip assays for glucose and leucocytes; i.e. those with peroxide-linked endpoints. The effect of increased HPLA was less marked.<h4>Conclusions</h4>In patients with AKU or on nitisinone treatment and HT-1 patients on nitisinone, urine strip chemistry testing should be used sparingly, if at all, to avoid false negative reporting. It is recommended that urine assays should be organised with a suitable specialist laboratory.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Alkaptonuria, Hydroxyphenylpyruvic acid, Hydroxyphenyllactic acid, Tyrosine, Nitisinone, Interference, Routine clinical analysis, Creatinine, Urate, Peroxide |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 23 Feb 2022 12:21 |
| Last Modified: | 18 Jan 2023 21:11 |
| DOI: | 10.1016/j.clinbiochem.2019.06.010 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3149503 |
Dimensions
Dimensions
